Clinical observation of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis in the early and mid-term stage

ZHANG Qiang; CAO Yifa; HU Jianshan; LI Pu; HU Jing; LU Yaoyu; SU Jun; LIANG Zicong; YANG Zhu

doi:10.6039/j.issn.1001-0408.2023.09.14

您当前的位置：

首页 >

文章列表页 >

Clinical observation of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis in the early and mid-term stage

更新时间：2023-11-06

- Clinical observation of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis in the early and mid-term stage
- ZHONGGUO YAOFANG Vol. 34, Issue 9, Pages: 1099-1103(2023)
- 作者机构：
  
  1.贵州省黔南布依族苗族自治州中医医院/贵州中医药大学第三附属医院骨伤科，贵州都匀　558000
  2.贵州水族药物开发有限责任公司，贵州三都　558100
  3.贵州中医药大学骨伤学院，贵阳　550025
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.09.14
  CLC： R969.3;R979.9
- Published：15 May 2023，
  
  Received：27 October 2022，
  
  Revised：18 April 2023，
扫描看全文
张强,曹益发,胡建山等.鸡胚地龙贴膏联合双醋瑞因治疗早中期膝骨关节炎的临床观察 ^Δ[J].中国药房,2023,34(09):1099-1103.

ZHANG Qiang,CAO Yifa,HU Jianshan,et al.Clinical observation of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis in the early and mid-term stage[J].ZHONGGUO YAOFANG,2023,34(09):1099-1103.
张强,曹益发,胡建山等.鸡胚地龙贴膏联合双醋瑞因治疗早中期膝骨关节炎的临床观察 ^Δ[J].中国药房,2023,34(09):1099-1103. DOI： 10.6039/j.issn.1001-0408.2023.09.14.

ZHANG Qiang,CAO Yifa,HU Jianshan,et al.Clinical observation of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis in the early and mid-term stage[J].ZHONGGUO YAOFANG,2023,34(09):1099-1103. DOI： 10.6039/j.issn.1001-0408.2023.09.14.

摘要

目的

探讨鸡胚地龙贴膏联合双醋瑞因治疗早中期膝骨关节炎（KOA）的临床疗效及安全性。

方法

将100例KOA患者按随机数字表法分为对照组和试验组，每组50例。对照组患者口服双醋瑞因胶囊，每次50 mg，每日2次；试验组患者在对照组治疗基础上给予鸡胚地龙贴膏外贴，每日1次。两组疗程均为4周，疗程结束后3个月随访。观察两组患者的临床疗效，治疗前后及疗程结束后3个月随访时的视觉模拟评分法（VAS）评分、西安大略和麦克马斯特大学骨关节炎指数量表（WOMAC）评分、Lysholm膝关节功能评分，检测膝关节液中肿瘤坏死因子α（TNF-α）、白细胞介素1β（IL-1β）、IL-6、超氧化物歧化酶（SOD）、丙二醛（MDA）、一氧化氮（NO）、软骨寡聚基质蛋白（COMP）、基质金属蛋白酶13（MMP-13）和Ⅱ型胶原C端肽（CTX-Ⅱ）的水平，并记录不良反应发生情况。

结果

治疗4周后，试验组患者的总有效率为96.0%，对照组为90.0%，两组比较差异无统计学意义（

＞0.05）；疗程结束后3个月随访时，试验组患者的总有效率（94.0%）显著高于对照组（62.0%）（

＜0.05）。治疗4周后和疗程结束后3个月随访时，两组患者的VAS评分、WOMAC评分和膝关节液中TNF-α、IL-1β、IL-6、MDA、NO、COMP、MMP-13、CTX-Ⅱ水平均显著低于治疗前，Lysholm评分和膝关节液中SOD活性均显著高于治疗前，且同一时期试验组指标均显著优于对照组（

＜0.05）。两组患者不良反应发生率比较差异无统计学意义（

＞0.05）。

结论

鸡胚地龙贴膏联合双醋瑞因治疗早中期KOA，可通过抑制炎症反应、减少氧化应激反应、抑制软骨细胞及基质降解来减轻患者疼痛症状，改善患者膝关节功能，且不良反应发生率较低。

Abstract

OBJECTIVE

To investigate clinical efficacy and safety of Jipei dilong ointment combined with diacerein in the treatment of knee osteoarthritis （KOA） in the early and mid-term stage.

METHODS

Totally 100 KOA patients were randomly divided into control group and trial group， with 50 cases in each group. Control group received Diacerein capsules orally， 50 mg every time， bid. Trial group additionally received Jipei dilong ointment， once a day， on the basis of control group. Both groups had a treatment course of 4 weeks， and were followed up for 3 months after treatment. The clinical efficacy of 2 groups， visual analogue scale （VAS）， Western Ontario and McMaster University osteoarthritis index （WOMAC） score， Lysholm scores before and after treatment， at 3-month follow-up after treatment were all observed； the levels of tumor necrosis factor-α （TNF-α）， interleukin 1β （IL-1β）， IL-6， superoxide dismutase （SOD）， malondialdehyde （MDA）， nitric oxide （NO）， cartilage oligomeric matrix protein （COMP）， matrix metalloproteinase-13 （MMP-13） and C-telopeptide of type Ⅱ collagen （CTX-Ⅱ） were detected in knee joint fluid. The incidence of adverse drug reactions was recorded.

RESULTS

After 4 weeks of treatment， total effective rate was 96.0% in trial group and 90.0% in control group， without statistical significance between 2 groups （

＞0.05）. At 3-month follow-up after treatment， total effective rate of trial group was 94.0%， and was higher than 62.0% of control group （

＜0.05）. After 4 weeks of treatment and at 3-month follow-up after treatment， VAS score， WOMAC score，the contents of TNF-α， IL-1β， IL-6， MDA， NO， COMP， MMP-13 and CTX-Ⅱ in knee joint fluid of two groups were significantly lower than before； Lysholm score and SOD activity of knee joint fluid were significantly higher than before， and the trial group was significantly better than the control group during the same period （

＜0.05）. And there was no statistical significance in the incidence of adverse drug reactions between two groups（

＞0.05）.

CONCLUSION

For the treatment of KOA in early and mid-term stage， Jipei dilong ointment combined with diacerein relieve pain， improve knee function by inhibiting inflammatory reaction， reducing oxidative stress and inhibiting chondrocyte and matrix degradation， and have low incidence of adverse drug reactions.

关键词

鸡胚地龙贴膏双醋瑞因膝骨关节炎炎症因子氧化应激

Keywords

diacereinknee osteoarthritisinflammatory factorsoxidative stress

references

宋阳春，吴三兵，胡谷丰，等. 痹祺胶囊联合刃针治疗膝骨性关节炎的疗效观察[J]. 中草药，2021，52（22）：6923-6927.

中华医学会骨科学分会关节外科学组. 骨关节炎诊疗指南：2018年版[J]. 中华骨科杂志，2018，38（12）：705-715.

中华医学会骨科分会关节外科学组，吴阶平医学基金会骨科学专家委员会. 膝骨关节炎阶梯治疗专家共识：2018年版[J/OL]. 中华关节外科杂志（电子版），2019，13（1）：124-130[2022-09-20]. https：//max.book118.com/html/2019/1011/5234303233002134.shtm.DOI：10.3877/cma.j.issn.1674-134X.2019.01.024https://max.book118.com/html/2019/1011/5234303233002134.shtm.DOI:10.3877/cma.j.issn.1674-134X.2019.01.024.

朱玉辉，邹来勇，曹耀兴. 强筋健骨胶囊联合双醋瑞因治疗膝骨性关节炎的临床研究[J]. 现代药物与临床，2022，37（10）：2339-2343.

胡恒，彭伟，张忠. 双醋瑞因胶囊结合艾瑞昔布片对膝骨关节炎患者的治疗效果及对COX-2、Wnt-3α、骨代谢水平的影响[J]. 河北医科大学学报，2022，43（2）：1716-1718.

黄朝晖，赵舟益. 化瘀祛湿方与双醋瑞因胶囊治疗早期膝骨关节炎的临床疗效比较[J]. 浙江医学，2020，42（12）：1327-1328.

刘峰廷，武丽娜，阎博华，等.水族鸡胚地龙膏加羼杂疗法在中医外治法中的研究进展[J].中国民族医药杂志，2023，29（1）：76-80.

李溥，黄月娜，杨丽，等. 鸡胚地龙膏对兔急性软组织损伤血清及组织液中疼痛指标的影响[J]. 右江医学，2011，39（5）：545-549.

郑筱萸. 中药新药临床研究指导原则：试行[M]. 北京：中国医药科技出版社，2002：349-353.

井含光，孟庆刚. 单病例随机对照试验在中医药临床疗效评价中的应用与要点分析[J]. 中华中医药学刊，2018，36（4）：890-893.

曹靖. 关节腔内注射血小板裂解液和倍他米松对膝骨关节炎患者的临床疗效及对VAS评分的影响[J]. 中国伤残医学，2019，27（10）：61-62.

严攀，刘波，阴俊，等. 西安大略和麦克马斯特大学骨关节炎指数用于膝退行性骨关节炎患者评定的反应度研究[J]. 中国康复医学杂志，2016，31（2）：215-216.

黄乐春，胡惠民，梁宇翔. 膝关节功能评分量表评述[J]. 中国医药科学，2016，6（13）：50-53.

LEVINGER P，NAGANO H，DOWNIE C，et al. Biomechanical balance response during induced falls under dual task conditions in people with knee osteoarthritis[J]. Gait Posture，2016，48：106-112.

葛洪，刘畅，李怡良，等. 麝香乌龙丸联合双醋瑞因胶囊治疗膝关节骨关节炎疗效及对IL-1β、IL-6、TNF-α的影响[J]. 现代中西医结合杂志，2021，30（13）：1385-1388，1393.

周京华. 金乌骨通胶囊对骨性关节炎患者关节液中氧化应激指标及炎性因子水平的影响[J]. 现代中西医结合杂志，2019，28（4）：409-412.

吴刚，张永锋. 参麦注射液关节腔注射治疗膝骨性关节炎疗效及对患者关节滑液基质金属蛋白酶、透明质酸、一氧化氮浓度的影响[J]. 陕西中医，2020，41（1）：35-37.

郭健，邢乾龙，胡滨，等. IL-1β、IL-1和MMP-13在膝关节骨性关节炎中的表达及临床意义[J]. 分子诊断与治疗杂志，2022，14（8）：1363-1366.

柳晓峰，安玉芳，崔立建. 乌头注射液对膝关节骨性关节炎模型兔体内COMP、p53蛋白、BMP-2等因子的影响[J]. 中国药房，2020，31（6）：714-718.

方剑利，楼红侃，金甬，等. 补肾通络法治疗膝关节骨性关节炎肾虚血瘀证的临床疗效及对骨代谢指标的影响[J]. 中华中医药学刊，2022，40（7）：82-86.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Improvement mechanism of proanthocyanidins on gentamicin-induced acute kidney injury of rats through SIRT1/AMPK signaling pathway

Neuroprotective effect and mechanism of celastrol and its derivatives in vitro

Impacts of andrographolide on sciatic nerve function damage in diabetic peripheral neuropathy rats by regulating HMGB1/RAGE signaling pathway

Effects and mechanism of Hugan buzure formula on intrahepatic cholestatic liver injury in rats

脑心通胶囊治疗血管性痴呆的疗效及对患者氧化应激指标影响的临床观察

Related Author

LI Shanshan

XIE Taomei

FU Shushan

FU Shengliang

JIANG Qiang

FU Meili

ZHANG Xin

CHEN Peipei

Related Institution

Dept. of Nephrology， Danzhou People’s Hospital

Dept. of Endocrinology， Danzhou People’s Hospital

College of Pharmacy， Fujian University of Traditional Chinese Medicine

State Key Laboratory of Dao-di Herbs， China Academy of Chinese Medical Sciences

Dept. of Orthopaedics， Heilongjiang Mudanjiang Forestry Central Hospital

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰